Overview

Apoptosis Assays Market Introduction 

Global apoptosis assays market is anticipated to value around USD 4.7 billion by 2027 end and register a CAGR of over 9.4% from the forecast period 2020-2027.

The mounting funds assigned for cancer research coupled with innovations on apoptosis assays drugs are the driving factors expanding the market. Additionally, increased cell-based research along with rising cases of infectious diseases is positively influencing the market.
 
Apoptosis Assays Market Overview 
The market is bifurcated into by product, by detection technology, by application, by end-user and region. In terms of product, assay kits are expected to dominate the growth of the market. 
The ability of assay kits to detect nuclear changes coupled with the adoption of assay kits in multiple procedures like environmental monitoring, life science research is stimulating the market. It is also used in the screening of drug candidates, evaluating biopharmaceutical production processes and studying diseases. Owing to these features, assay kits are expected to hold a majority share of the market.
In terms of detection technology, cell imaging and microscopy are forecasted to witness notable growth owing to the increasing preference towards cell imaging and microscopy in drug discovery applications, basic research, and diagnostic laboratories.
Based on application, drug discovery and development holds a vast share of the market. The increasing prevalence and incidence of infectious and chronic diseases are driving the demand for drug discovery and development. The increasing research and development activities coupled with mounting government efforts taken to develop new treatments for multiple diseases is expanding the apoptosis synthesis market size. 

North America is the global leader of the market. Increasing incidences of chronic diseases and soaring investments for cancer research is fueling the market growth in the region. Furthermore, soaring research and development activities alongside favourable government policies in the region are boosting the market presence in the region. 

Asia-Pacific region is expected to be a lucrative region owing to increased spending on the healthcare sector and the presence of a larger patient population. Moreover, the presence of a large number of local players coupled with increasing cases of infectious diseases is positively influencing the market in the region.
Prominent players of the market are Danaher Corporation, BioTek Instruments, Promega Corporation, PerkinElmer, Abcam plc, Abnova, Creative Bioarray, Thermo Fisher Scientific, Merck KgaA, Becton, GE Healthcare, Dickinson and Company, Geno Technology GeneCopoeia, Inc and Sartorius.

Competitive Landscape:
·      Merck acquired Sigma Aldrich Corporation. The move helped Merck to strengthen its life science segment
·      Thermo Fisher Scientific in 2018, launched Multiskan Sky Microplate Spectrophotometer
·      Dickinson and Company and Becton in 2017 acquired C.R Bard
·      GE Healthcare Life Sciences opened its new manufacturing site in Austria in 2018. The move will help the company strengthen its product supply all over Europe
 
Apoptosis Assays Market Segmentation
By Product
●     Assay Kits
▪      Caspase Assays
▪      Annexin V and Cell Permeability Assays
▪      DNA Fragmentation Assay
▪      Mitochondrial Assays
●     Reagents
●     Microplates
●     Instruments

By Detection Technology
●     Flow Cytometry
●     Cell Imaging & Analysis Systems
●     Spectrophotometry
●     Other Detection Technologies
 
By Application
●     Basic Research
●     Clinical & Diagnostic Applications
●     Drug Discovery & Development
●     Stem Cell Research

By End User
●     Hospital and Diagnostic Laboratories
●     Pharmaceutical and Biotechnology Companies
●     Academic and Research Institutes
 
By Region
●     North America
●     Europe
●     Asia Pacific
●     Latin America
●     Rest of the World
 

FutureWise Key Takeaways
●  Growth Prospects
●  SWOT Analysis
●  Key Trends
●  Key data-points affecting market growth
 
Objectives of the Study:
• To provide with an exhaustive analysis on the apoptosis market by product, by detection technology, by application, by end-user and by region 
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• Evaluate and forecast micro-markets and the overall market 
• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and the rest of the world
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financial and core competencies

Table of Contents

Table of Contents

1 Introduction 

    1.1 Objectives of the Study 

    1.2 Market Definition 

    1.3 Market Scope 

           1.3.1 Markets Covered

           1.3.2 Years Considered for the Study

    1.4 Currency 

    1.5 Limitations 

    1.6 Stakeholders 

 

2 Research Methodology 

    2.1 Research Data 

           2.1.1 Secondary Data

                    2.1.1.1 Key Data From Secondary Sources

           2.1.2 Primary Data

                    2.1.2.1 Key Data From Primary Sources

                    2.1.2.2 Break Down of Primary Sources

    2.2 Market Size Estimation 

    2.3 Market Breakdown and Data Triangulation 

    2.4 Market Share Estimation 

    2.5 Assumptions for the Study 

 

3 Executive Summary 

4 Premium Insights 

    4.1 Apoptosis Assays Market Overview 

    4.2 Apoptosis Assays Market: Geographic Overview (2018) 

    4.3 Regional Mix: Apoptosis Assays Market (2019–2027) 

    4.4 Asia Pacific: Apoptosis Assays Market, By End User & Country (2018) 

    4.5 Apoptosis Assays Market: Developed vs Developing Markets 

 

5 Market Overview 

    5.1 Introduction 

    5.2 Market Dynamics 

           5.2.1 Drivers

                    5.2.1.1 Rising Incidence and Prevalence of Chronic and Infectious Diseases

                    5.2.1.2 Growing Funding for Cancer Research

                    5.2.1.3 Growing Cell-Based Research

                    5.2.1.4 Development of Apoptosis-Modulating Drugs

           5.2.2 Restraints

                    5.2.2.1 High Investments Required for Research and Development

           5.2.3 Opportunities

                    5.2.3.1 Emerging Markets

 

6 Industry Insights 

    6.1 Introduction 

    6.2 Industry Trends 

           6.2.1 Increasing Adoption of Apoptosis-Targeting Therapy in Cancer Treatment

           6.2.2 Technological Advancements

                    6.2.2.1 Label-Free Detection and Imaging of Apoptosis

                    6.2.2.2 Microfluidic Devices for the Analysis of Apoptosis

    6.3 Unmet Need 

           6.3.1 Unavailability of 3D Apoptosis Assays

 

7  By Product 

    7.1 Introduction 

           7.1.1 Assay Kits

                    7.1.1.1 Caspase assays

                               7.1.1.1.1 Caspase Assays to Dominate the Assay Kits Market During the Forecast Period

                    7.1.1.2 Annexin V and Cell Permeability Assays

                               7.1.1.2.1 Annexin V & Cell Permeability Assays are Among the Most Commonly Used Apoptosis Assays Due to Their Ability to Bind to Phosphatidylserine

                    7.1.1.3 DNA Fragmentation Assays

                               7.1.1.3.1 Ability to Detect Nuclear Changes to Drive the Demand for DNA Fragmentation Assay Kits

                    7.1.1.4 Mitochondrial Assays

                               7.1.1.4.1 Merck, Thermo Fisher, Bio-Rad, and BD are Among the Key Players in the Mitochondrial Assays Segment

           7.1.2 Reagents

           7.1.3 Instruments

           7.1.4 Microplates

 

8 By Detection Technology 

    8.1 Introduction 

           8.1.1 Flow Cytometry

                    8.1.1.1 Flow Cytometry is the Most Popular Apoptosis Detection Technology Owing to Its Ability to Provide Quantitative Multi-Parametric Analysis

           8.1.2 Cell Imaging and Microscopy

                    8.1.2.1 Ability to Monitor Cell Physiology and Examine Complex Cellular Processes to Drive the Demand for Cell Imaging and Microscopy Technologies

           8.1.3 Spectrophotometry

                    8.1.3.1 Lower Instrument Cost as Compared to Flow Cytometers Drives Greater Adoption of Spectrophotometers in Academic Settings

           8.1.4 Other Detection Technologies

 

9 By Application 

    9.1 Introduction 

    9.2 Drug Discovery and Development 

           9.2.1 Drug Discovery and Development Forms the Largest Application Market for Apoptosis Assays

    9.3 Clinical and Diagnostic Applications 

           9.3.1 Rising Prevalence of Cancer, Blood-Related Disorders, & Infectious Diseases Driving the Demand for Apoptosis Assays for Clinical & Diagnostics Applications

    9.4 Basic Research 

           9.4.1 Growing Research Funding for Academic Institutions Likely to Support the Demand for Apoptosis Assays in Basic Research

    9.5 Stem Cell Research 

           9.5.1 Rapidly Growing Interest in Regenerative Therapies Driving the Demand for Apoptosis Assays in Stem Cell Research

 

10  By End User 

     10.1 Introduction 

     10.2 Pharmaceutical & Biotechnology Companies 

             10.2.1 Rising R&D Activities & Interest Towards Development of Apoptosis Targeted Therapies Likely to Drive the Market Growth Among Pharmaceutical & Biotechnology Companies

     10.3 Hospital & Diagnostic Laboratories 

             10.3.1 Increasing Number of Hospitals & High Prevalence of Chronic Diseases to Drive the Market Growth Among Hospital & Diagnostic Laboratories

     10.4 Academic & Research Institutes 

             10.4.1 Growing Drug Discovery Research in Academic Institutions to Propel the Demand for Apoptosis Assays

 

11  By Region 

     11.1 Introduction 

     11.2 North America 

             11.2.1 US

                       11.2.1.1 Increasing Demand for Early and Effective Disease Diagnosis and Treatment to Drive the Growth of the Apoptosis Assays Market in the Us

             11.2.2 Canada

                       11.2.2.1 Number of Government Initiatives to Support Life Sciences Research to Drive the Apoptosis Assays Market in Canada

     11.3 Europe 

             11.3.1 Germany

                       11.3.1.1 Well-Established R&D Infrastructure & Large Number of Academic Research Institutes Account for Large Share of Germany in European Market

             11.3.2 France

                       11.3.2.1 Support From Government and Private Investors for Promoting Research in Cell Therapy to Drive the Growth of the  Market in France

             11.3.3 UK

                       11.3.3.1 Growing Prevalence of Cancer and Neurological Disorders & Increasing R&D Investments to Drive the Demand for Apoptosis Assays in the UK

             11.3.4 Italy

                       11.3.4.1 Increasing Prevalence of Target Diseases Driving the Demand for Apoptosis Assays in Italy

             11.3.5 Spain

                       11.3.5.1 Increasing Private and Public Funding for Cell-Based Research to Drive the Growth of the Market in Spain

             11.3.6 Rest of Europe

     11.4 Asia Pacific 

             11.4.1 Japan

                       11.4.1.1 High Prevalence of Cancer and Expansion of Cancer Research to Drive the Growth of the Market in Japan

             11.4.2 China

                       11.4.2.1 Increasing Prevalence of Chronic Diseases and Expanding Biopharmaceutical Research Propelling the Growth of the Market in China

             11.4.3 India

                       11.4.3.1 Geographic Expansion of Pharmaceutical Companies and Increasing Cell-Based Research Expected to Drive the Demand for Apoptosis Assays in India

             11.4.4 Rest of Asia Pacific

     11.5 Latin America 

             11.5.1 Increasing Funding for Life Sciences Research to Drive the Demand for Apoptosis Assays in Latin America

     11.6 Middle East & Africa 

             11.6.1 Increasing Number of Partnerships in the Research Sector Driving the Market Growth in the Middle East & Africa

 

12 Competitive Landscape 

     12.1 Overview 

     12.2 Market Share Analysis 

             12.2.1 Market Share Analysis: Apoptosis Assay Kits Market

     12.3 Competitive Situation and Trends 

             12.3.1 Product Launches

             12.3.2 Expansions

             12.3.3 Acquisitions

             12.3.4 Other Strategies

 

13 Company Profiles 

(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, FutureWise Perspective)*

     13.1 Merck KGaA 

     13.2 Thermo Fisher Scientific Inc. 

     13.3 Becton, Dickinson and Company 

     13.4 Bio-Rad Laboratories 

     13.5 Promega Corporation 

     13.6 Abcam PLC  

     13.7 Bio-Techne Corporation 

     13.8 Sartorius AG 

     13.9 Biotium 

     13.10 Creative Bioarray (A Part of Creative Dynamics Inc.) 

     13.11 Geno Technology, Inc. 

     13.12 GeneCopoeia, Inc. 

     13.13 Danaher Corporation 

     13.14 GE Healthcare 

     13.15 Biotek Instruments 

     13.16 PerkinElmer

 

14. Research Finding and Conclusion 

14. Appendix 

16.1 Research Methodology 

16 .2 Research Data Source

Tables

Figures